Ackrell Capital, LLC
OrganizationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
FINRA / SIPC
|
Membership |
7
|
3 | |
|
organization
FINRA
|
Membership |
6
|
2 | |
|
organization
SIPC
|
Membership |
6
|
2 | |
|
organization
Wana Brands
|
Investment analysis |
5
|
1 | |
|
person
FINRA/SIPC
|
Membership |
5
|
1 | |
|
organization
VCC Brands
|
Investment analysis |
5
|
1 | |
|
organization
Uber
|
Investment analysis |
5
|
1 | |
|
organization
Vapexhale
|
Investment analysis |
5
|
1 | |
|
organization
SC Labs
|
Business associate |
1
|
1 |
HOUSE_OVERSIGHT_024757.jpg
This page from an Ackrell Capital report details capital raised by publicly traded cannabis companies for the year ending September 30, 2017, highlighting that Canadian companies raised significantly more capital than those in the U.S. or Australia. It also provides an overview of the U.S. public capital markets for cannabis, noting that while a few trade on major exchanges like Nasdaq and NYSE, the vast majority are "penny" stocks on the OTC market characterized by high risk and regulatory scrutiny from the SEC and FINRA.
HOUSE_OVERSIGHT_024755.jpg
This document is page 119 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It analyzes listing requirements for cannabis companies on US, Canadian, and Australian stock exchanges (NYSE, Nasdaq, OTC, TSX, CSE, ASX). It includes a statistical table summarizing market values, enterprise values, and revenue averages for cannabis-related companies as of November 30, 2017. The document bears a House Oversight Committee stamp.
HOUSE_OVERSIGHT_024753.jpg
This document is page 117 of a 2017 report by Ackrell Capital titled 'Chapter VII: Capital Markets for Cannabis Companies.' It acts as a market overview, detailing that while over $2 billion was raised in 2017, the sector is dominated by retail investors rather than institutional capital due to legal and maturity issues. The report notes that the majority of companies are early-stage with revenues under $5 million. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating its inclusion in a congressional investigation.
HOUSE_OVERSIGHT_024751.jpg
This document from Ackrell Capital provides a sensitivity analysis for the international legal cannabis market size, forecasting a potential global market exceeding $300 billion within 10-15 years. It includes estimates excluding major Asian markets but notes the potential for the market to exceed $500 billion if countries like China and Japan legalize cannabis. The page concludes with a disclaimer regarding the uncertainty of these predictions and potential risks to the industry.
HOUSE_OVERSIGHT_024748.jpg
Page 112 of a December 2017 Cannabis Investment Report by Ackrell Capital. The document analyzes the methodology of cannabis market estimates by comparing them to alcohol, coffee, tobacco, and pharmaceuticals, detailing adult penetration rates, monthly consumer spending, and U.S. retail market sizes. The document bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024747.jpg
This document is a page from a 2017 market research report by Ackrell Capital regarding U.S. legalized cannabis market estimates. It includes a bar chart projecting market growth and consumer numbers from 2016 to 2030, contingent on federal legalization milestones. It also provides a sensitivity analysis table showing estimated 2030 market size based on varying population penetration rates and monthly consumer spending. The document bears a House Oversight stamp, suggesting it was part of a larger document production.
HOUSE_OVERSIGHT_024746.jpg
This document is page 110 of an Ackrell Capital 'Cannabis Investment Report' dated December 2017. It features two charts projecting the U.S. legalized cannabis market from 2016 to 2030, focusing on consumer penetration rates and weighted average monthly consumer spending, contingent on various legislative milestones like FDA approvals and federal legalization. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was collected as part of a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024745.jpg
This document is page 109 of a 2017 market research report by Ackrell Capital, LLC, titled 'U.S. and International Cannabis Market Estimates.' It analyzes consumer penetration rates for the cannabis industry, discussing variables such as age groups, state laws (medical vs. recreational), and dispensary networks. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a Congressional investigation, though the text itself contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024743.jpg
This document is page 107 of a report by Ackrell Capital, LLC regarding U.S. and International Cannabis Market Estimates. It specifically analyzes the market growth in Oregon and California following the implementation of medical and recreational laws, providing bar charts with financial estimates for market size through 2017 and 2018. The document bears a 'HOUSE_OVERSIGHT' bates stamp, indicating it was part of a document production for a Congressional investigation.
HOUSE_OVERSIGHT_024742.jpg
This document is page 106 of a Cannabis Investment Report dated December 2017 by Ackrell Capital. It presents data and graphs analyzing the State-Legal Cannabis Markets in Colorado and Washington, specifically tracking growth in millions of dollars following the implementation of medical and recreational laws between 2013 and 2017 (estimated). The page bears a 'HOUSE_OVERSIGHT_024742' stamp, indicating it is part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024741.jpg
This document is page 105 of a 2017 financial report by Ackrell Capital regarding the U.S. State-Legal Cannabis Market. It estimates the 2017 market value at $8.0 billion, provides a pie chart breaking down revenue by state (California, Colorado, Washington, Oregon), and discusses recreational sales as a key driver for market expansion. The page bears the stamp 'HOUSE_OVERSIGHT_024741', indicating it was part of a document production for the House Oversight Committee.
HOUSE_OVERSIGHT_024740.jpg
This document is page 104 of a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It analyzes market trends, including the medical efficacy of cannabis, the increase in recreational legalization (citing Uruguay, Canada, and US states like Colorado and California), product innovation, and pricing dynamics between legal and illegal markets. The document bears a 'HOUSE_OVERSIGHT_024740' stamp, indicating it was part of a document production for a Congressional investigation, though the text itself contains no direct references to Jeffrey Epstein or specific individuals.
HOUSE_OVERSIGHT_024739.jpg
This document is page 103 of a 2017 report by Ackrell Capital, LLC regarding U.S. and International Cannabis Market Estimates. It analyzes global market data provided by the UNODC and RAND Corporation, estimating the illegal market value in the billions. It also outlines predictions for U.S. federal legalization, suggesting a pathway involving FDA approvals and state-level adoption. The document bears the Bates stamp HOUSE_OVERSIGHT_024739, indicating it was part of a document production for a House Oversight Committee investigation, likely related to financial probes involving Epstein or associated entities.
HOUSE_OVERSIGHT_024737.jpg
This page from an Ackrell Capital report discusses the global outlook for cannabis regulation, identifying 2018 as a critical year due to recreational legalization efforts in Canada and California. It argues that the future stance of the U.S. federal government regarding enforcement or legalization will be the single most impactful factor on the global industry's trajectory.
HOUSE_OVERSIGHT_024736.jpg
This page from a 2017 Ackrell Capital Cannabis Investment Report details the legal status and recent developments regarding medical cannabis in Greece, the United Kingdom, and regions across the Middle East, Asia, and Africa. It highlights specific legislative changes in South Africa and Lesotho, as well as Israel's established medical cannabis program and its 2017 move to allow exports.
HOUSE_OVERSIGHT_024735.jpg
This document is page 99 of a 2017 market research report by Ackrell Capital regarding global cannabis regulation. It details the legal status and legislative progress of medical cannabis in New Zealand and various European countries, including Italy, Croatia, Germany, Poland, the Netherlands, and Spain. The document bears a 'HOUSE_OVERSIGHT_024735' stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024732.jpg
This document is page 96 of a Cannabis Investment Report published by Ackrell Capital in December 2017. It details legal developments regarding cannabis legalization and medical use in the United States and Canada, referencing specific legislation like the CSA and CDSA. The document contains a 'HOUSE_OVERSIGHT_024732' Bates stamp, indicating it was included in document production for a House Oversight Committee investigation, likely as part of a larger financial or investment portfolio review, though the text itself contains no direct references to Epstein or his associates.
HOUSE_OVERSIGHT_024730.jpg
This document is page 94 of a 'Cannabis Investment Report' published by Ackrell Capital in December 2017. It provides a detailed regulatory analysis of United Nations drug control conventions (1961, 1971, and 1988) regarding the scheduling and prohibition of substances like THC and cannabis. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024730', indicating it was part of a document production to the House Oversight Committee, likely during an investigation involving financial records or investments.
HOUSE_OVERSIGHT_024729.jpg
This document is page 93 of a 2017 report by Ackrell Capital regarding global cannabis regulation. It discusses international partnerships, banking challenges related to anti-money laundering laws (specifically focusing on U.S. and Uruguayan banking conflicts), and outlines United Nations conventions from 1961 and 1971 regarding narcotic and psychotropic substances. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024728.jpg
This document is page 92 of a 'Cannabis Investment Report' dated December 2017 by Ackrell Capital, LLC. It features a world map and lists categorizing countries by their cannabis laws (Medical, Recreational, or State/Federal Conflict). The document bears a 'HOUSE_OVERSIGHT_024728' Bates stamp, indicating it was part of a document production for a congressional investigation, likely related to financial oversight.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity